A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
Clinical trial NCT03530397 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03530397
- Sponsor
- MedImmune LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2025-07-14
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.